Home ORIGIANT

ORIGIANT

In operation
Series A
Small Molecule New Drug Developer
Basic
Enterprise Profile

Basic Information

ORIGIANT is an innovative R&D-driven AI + biopharmaceutical company. ORIGIANT focuses on the research and development of small molecule new drugs in major disease areas such as oncology and immunology. All of its self-developed new drug products are original global new drugs, designed to meet significant unmet clinical needs of patients in China and globally, with substantial technical advantages and enormous market potential.
ORIGIANT
Sichuan,China
15~50 people
July 03, 2020
hr@origiant.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Biological Drug Production
Concept
Ophthalmology Tumor Immune System Diseases Ocular Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs AI+Pharmaceuticals